JPY 2,310.50
+27.50 (+1.20%)
JPY · as of 2026-08-18 · marketstack
| Size & multiples | |||
| Market Cap | JPY 4.18T | Enterprise Value | JPY 4.47T |
| P/E (TTM) | 14.24× | PEG (trailing) | 0.32× |
| P/S | 1.95× | P/FCF | 6.77× |
| EV/EBITDA | — | EV/EBIT | 11.67× |
| EV/Sales | 2.09× | EV/FCF | 7.23× |
| FCF Yield | 14.78% | Buyback Yield | — |
| Owner Earnings Yield | — | Shareholder Yield | — |
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | −0.05 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 4.23% | Cost of Equity | — |
| After-tax Cost of Debt | 1.93% | WACC | — |
| ROIC | 13.87% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows latest annual · EPS TTM JPY 162.22 · revenue TTM JPY 2.14T · FCF TTM JPY 617.91B (in JPY)
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
| Metric | Today | Own median | Own range | %ile | z | Sector med. | mo · distinct |
|---|---|---|---|---|---|---|---|
| P/E | 14.07× | only 2 monthly observations — under the 12-month floor for a series line. P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one. | |||||
| 17.4% | — | no band (13 mo · 2 distinct) | — | — | −36.9% | 13 · 2 | |
| 13.9% | — | no band (13 mo · 2 distinct) | — | — | −15.4% | 13 · 2 | |
| 13.6% | — | no band (13 mo · 2 distinct) | — | — | −21.3% | 13 · 2 | |
| 46.0% | 4.4% | 96th | +2.45σ | 5.1% | 141 · 140 | ||
| EPS Growth 3Y | 44.2% | only 2 monthly observations — under the 12-month floor for a series line. P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one. | |||||
| 12.1% | — | no band (13 mo · 2 distinct) | — | — | 9.0% | 13 · 2 | |
| Market Cap | $25.97B | not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series. | |||||
shown for reference only — the reconstructed distribution did not clear the band gate, so no rank is quoted.
Filed earnings only.
no P/E ladder — only 2 monthly observations — under the 12-month floor for a series line. P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Loading the monthly cohort placement…
Cheap vs Health Care on P/E
P/E 26th pct
Whole-sector pool — median skews small.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 14.1x | 26.0x | 13.7x–39.9x | 26 ↓cheap |
| EV/Sales | 2.1x | 3.3x | 1.7x–7.9x | 32 ↓cheap |
| FCF Yield | 15.0% | -7.2% | -32.9%–1.4% | 97 ↑strong |
| Net Margin | 13.6% | -21.3% | -329.2%–7.1% | 84 ↑strong |
| Operating Margin | 17.9% | -34.7% | -552.6%–8.0% | 88 ↑strong |
| ROE | 17.4% | -36.9% | -92.5%–4.5% | 88 ↑strong |
Reading the covered industry pool…
Held-with peers…
Peers by disclosure language…
This company has no published industry pool year: either its industry group is untagged in our universe, we hold no annual revenue for it, or its group's newest year has not cleared the filing-alignment guard yet. This is a coverage gap, not a statement about the company.